Search

Population analysis of MG-ADL total score for efgartigimod Phase 3 study in myasthenia gravis patients: application of a bounded-integer model.

Therapeutic area :

Marostica E., Ahsman M., Bragt van T., Noukens J., Vis P., T’joen C., Ulrichts P., Guglietta A., Rossenu S., Steeg van T. Population analysis of MG-ADL total score for efgartigimod Phase 3 study in myasthenia gravis patients: application of a bounded-integer model. PAGE 2024 [Link to publication]

Our expertise

Biologicals Lung Diseases Methods Gastrointestinal Diseases Anesthesiology CNS Pain Safety pharmacology Paediatrics Cardiovascular Oncology Blood disorders Anti-infectives and immunology General modelling Endocrinology/Sexual health Peripheral Nervous System Diabetes